CAR-T cells can be controlled by light to target skin tumors in mice
Bioengineers from the University of California San Diego (CA, USA) have developed a novel method using light, designed to control the targeting of CAR-T cells. The study is published in Science Advances and reports the results of testing the system on mice with skin tumors. The system could potentially make CAR-T therapy safer and more powerful when treating cancer. CAR-T therapy allows a more tailored approach to cancer therapy as it involves genetically engineering a patient’s T cells to target cancer cells. This approach has so far worked well for some blood cancers, however, it is yet to prove effective...